Co‐treatment with a novel BRD4 inhibitor (ACC010) and homoharringtonine (HHT) synergistically inhibited cell proliferation, induced apoptosis, and arrested the cell cycle in AML with FLT3‐ITD mutation. This evidence concerns the gene FLT3 and acute myeloid leukemia.